Genencor (GCOR)- Recent IPO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genencor (GCOR)- Recent IPO

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (15)	2/29/2004 9:33:51 PM
From: richardred	of 58

old PR The company's recently signed collaboration with Seattle Genetics strengthens the company's targeted cancer therapeutics program and gives Genencor access to an advanced stage lead compound. corporate-ir.net

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next